This Master's Degree will allow you to incorporate into your professional practice the most updated concepts when it comes to elaborating a Business Plan"

Business Management in the Pharma Biotech field involves facing unique challenges due to the regulated and highly competitive nature of the pharmaceutical and biotechnology industry. The continuous progress of scientific knowledge, technological innovation and ever-changing regulations have generated the need for updating for key players in this sector. For this reason, TECH has created this program, which provides the physician with cutting-edge concepts in these fields, as well as high skills in organizational and financial matters to optimally manage a company. In addition, this program is taught in a 100% online format, favoring a study adapted to the personal and professional needs of the student.

Pharma Biotech Business Management plays a vital role in the medical field by providing effective and efficient strategic management to companies in the pharmaceutical and biotechnology industry. Its importance lies in its ability to guide and make informed decisions in a highly regulated and competitive environment. In this way, it drives the research and development of new drugs and innovative therapies, which in turn contributes to the advancement of medicine and the improvement of people's quality of life. To carry out all these actions, the top managers of these companies must have high organizational skills and cutting-edge clinical knowledge.

With this in mind, TECH has created this Master's Degree, which offers doctors an excellent update in the field of Pharma Biotech Business Management. During 12 months of intensive study, the student will delve into the cutting-edge strategies to establish the analysis of the environment and competition or the methods to undertake the budget planning of companies in the pharmaceutical and biotechnology industry. They will also delve into the development of a business plan for a company in the sector.

All this will be achieved without the doctor having to give up their usual personal and professional responsibilities, as this program is offered in an innovative 100% online format. Likewise, multimedia materials will be available in a virtual library, which can be accessed at any time and place, since it only requires a device with an internet connection. Furthermore, the wide variety of multimedia formats offered will preserve a pleasant, individualized and decisive teaching.

With this degree, you will delve into the most cutting-edge strategies when it comes to leading teams in the pharmaceutical industry"

This Degree diploma in MBA in Pharma Biotech Business Management contains the most complete and up-to-date program on the market. Its most notable features are:

• The development of practical cases presented by experts in Pharma Biotech
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

Through the 100% online modality, this refresher program will allow you to study from anywhere and at any time of the day." 

The program’s teaching staff includes professionals from the field who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.  

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to prepare for real situations

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise throughout the program. For this purpose, the students will be assisted by an innovative interactive video system created by renowned and experienced experts.

Update your knowledge of biotechnology company management through the professional experience of leading specialists in this health area"

Throughout this course, you will delve into the most advanced strategies for integrating new drugs into the market"

The Professional Master's Degree MBA in Pharma Biotech Business Management will focus on the interdisciplinary aspects of the pharmaceutical and biotechnology industry, highlighting its broad scope and up-to-date approach. During the 12 months of this degree, the physician will have access to innovative teaching materials such as videos, interactive summaries and simulations of real cases. These state-of-the-art resources will provide an enjoyable and effective educational experience. In addition, being a 100% online program, you will have the flexibility to study on your own schedule, without restrictions. 

The Relearning method will allow you to optimize your study hours and improve your understanding of long-term knowledge" 

Module 1. Strategic Management in the Pharmaceutical and Biotechnology Industry

1.1. Go-to-Market Strategies

1.1.1. Market Research
1.1.2. Strategic Partners
1.1.3. Most used Strategies
1.1.4. Monitoring and Adaptation

1.2. Strategic Management in the Pharmaceutical Enterprise

1.2.1. Management Levels
1.2.2. Innovation
1.2.3. Portfolio
1.2.4. Acquisition

1.3. Creating Corporate Value

1.3.1. The 6 Types of Value Generation in the Company
1.3.2. Performance in the Company
1.3.3. Examples from the Sector
1.3.4. Conclusions

1.4. The Pharmaceutical and Biotechnology Business Environment

1.4.1. VUCA Environment
1.4.2. PESTEL Analysis
1.4.3. Porter’s 5 Forces Analysis
1.4.4. DAFO Analysis

1.5. Internal Analysis

1.5.1. Analysis of the Value Chain
1.5.2. Analysis of Skills and Resources
1.5.3. VRIO Analysis
1.5.4. Conclusions

1.6. Strategic Business Unit Strategies

1.6.1. Strategic Business Unit Strategies
1.6.2. The Competitive Advantage
1.6.3. Types of Strategies According to their Competitive Advantage
1.6.4. Conclusions

1.7. Corporate Strategy and Diversification

1.7.1. Corporate Strategy
1.7.2. Business Portfolio Strategy
1.7.3. Growth Strategies
1.7.4. Most used Strategies

1.8. Internationalization Strategies

1.8.1. International Strategy of a Company
1.8.2. The Globalization of the Economy
1.8.3. Risks of Internationalization
1.8.4. Benefits of Internalization

1.9. Strategic Alliances, Takeovers and Mergers

1.9.1. External vs. Internal Growth Strategy
1.9.2. Partnerships in the Pharmaceutical Industry
1.9.3. Sector Mergers
1.9.4. Sector Acquisitions

1.10. Ethics and Corporate Social Responsibility

1.10.1. Business Ethics
1.10.2. Environmental Sustainability
1.10.3. Social Responsibility
1.10.4. Sustainable Economy

Module 2. Marketing in Pharma Biotech

2.1. Omnichannel, Impacts and Engagement

2.1.1. Impact Marketing
2.1.2. General Channels and Social Networks
2.1.3. Community Management
2.1.4. E-detailing and CRM in the Digital Environment
2.1.5. Programmed Advertising
2.1.6. Analytics and Business Indicators

2.2. Segmentation, Positioning and Targeting

2.2.1. Segmentation
2.2.2. The Positioning Map
2.2.3. Targeting
2.2.4. Conclusions

2.3. Management

2.3.1. The Marketing System
2.3.2. Information Acquisition
2.3.3. Research Process
2.3.4. Conclusions

2.4. Managing Brand and Neuromarketing

2.4.1. Branding
2.4.2. Branding Types
2.4.3. Neuromarketing and Application in the Pharmaceutical Industry
2.4.4. Conclusions

2.5. Digital Marketing Plans

2.5.1. Integrating Digital Marketing into the Global Marketing Strategy
2.5.2. Community Manager
2.5.3. Digital Marketing Plans
2.5.4. Target Audience

2.6. E-Commerce

2.6.1. The Conversion Cycle
2.6.2. E-Commerce Promotion
2.6.3. Metrics
2.6.4. e-Commerce Platforms

2.7. Digital Strategies

2.7.1. Social Media Strategies. Content Co-Creation
2.7.2. Content Marketing and Influencers
2.7.3. Digital Marketing to Support Leadership in the Therapeutic Area
2.7.4. Patient Associations

2.8. Design of Digital Programs

2.8.1. Definition of Objectives
2.8.2. Brand Strategy Support Programs: Disease Awareness, Switching
and Engagement
2.8.3. Digital Marketing and the Sales Network
2.8.4. Target

2.9. Data Analytics and Artificial Intelligence

2.9.1. Big Data Applications in the Pharmaceutical Industry
2.9.2. Artificial Intelligence Tools to Support Diagnosis
2.9.3. Artificial Intelligence Tools to Support Critical Patient Management
2.9.4. Latest Developments

2.10. Other Technology

2.10.1. Electronic Records and Information Gathering
2.10.2. Web 3 and New Trends in the Token Economy. Impact in the Pharmaceutical Industry
2.10.3. Virtual, Augmented and Mixed Reality
2.10.4. Metaverse

Module 3. Human Resources Management

3.1. Personnel Selection

3.1.1. Recruitment Process
3.1.2. Resume Review
3.1.3. Recruitment Interviews
3.1.4. Aptitude Tests and Psychometric Assessments

3.2. Compensation and Benefits

3.2.1. Compensation System Design
3.2.2. Elaboration of Variable Compensation
3.2.3. Benefit Design
3.2.4. Emotional Salary

3.3. Performance Management

3.3.1. Performance Evaluation
3.3.2. Talent and Improvement Programs
3.3.3. Feedback Meetings
3.4.3. Talent Retention and Loyalty Programs

3.4. Emotional Intelligence in the Work Environment

3.4.1. Emotional Awareness
3.4.2. Emotion Management
3.4.3. Empathy at Work
3.4.4. Social Skills and Collaboration

3.5. Training and Continuous Development

3.5.1. Career Plans
3.5.2. Specific Skills Development
3.5.3. Internal Promotion and Growth Opportunities
3.5.4. Adaptation to the Workplace

3.6. Team Management and Leadership

3.6.1. Effective Team Building
3.6.2. Inspirational Leadership
3.6.3. Effective Communication
3.6.4. Conflict Resolution

3.7. Organizational Adaptability and Flexibility

3.7.1. Change Management
3.7.2. Flexibility in Labor Policies
3.7.3. Human Resources Innovation
3.7.4. Adapting to New Technologies

3.8. Diversity and Inclusion in the Workplace

3.8.1. Diversity Promotion
3.8.2. Equal Opportunity
3.8.3. Creation of Inclusive Environments
3.8.4. Diversity Awareness and Training 

3.9. Positive Psychology at Work

3.9.1. Positive Organizational Culture
3.9.2. Workplace Well-Being
3.9.3. Promotion of Positive Attitudes
3.9.4.Resilience and Coping in the Workplace

3.10. Technology and Human Resources

3.10.1. Automation in Human Resources Processes
3.10.2. Data Analysis for Decision Making
3.10.3. Tools in Human Resources Management
3.10.4. Cybersecurity and Personal Data Protection

Module 4. Digital Health Management: Technological Innovation in the Health Sector 

4.1. Hospital Information Systems

4.1.1. Implementation
4.1.2. Management of Hospital Information Systems
4.1.3. Electronic Medical Records
4.1.4. Information Systems Interoperability

4.2. Telemedicine and Digital Health

4.2.1. Remote Medical Consultations
4.2.2. Tele-monitoring Platforms
4.2.3. Patient Monitoring
4.2.4. Mobile Health and Wellness Applications

4.3. Big Data and Data Analysis in Healthcare

4.3.1. Management and Analysis of Large Volumes of Data in Health
4.3.2. Use of Predictive Analysis for Decision-Making
4.3.3. Privacy
4.3.4. Health Data Security

4.4. Artificial Intelligence and Machine Learning in Healthcare

4.4.1. Artificial Intelligence Applications in Medical Diagnostics
4.4.2. Machine Learning Algorithms for Pattern Detection
4.4.3. Chatbots
4.4.4. Virtual Assistants in Medical Care

4.5. The Internet of Things (IoT) in Healthcare

4.5.1. Connected Medical Devices and Remote Monitoring
4.5.2. Intelligent Hospital Infrastructures
4.5.3. IoT Applications in Inventory Management
4.5.4. Supplies

4.6. Cybersecurity in Healthcare

4.6.1. Health Data Protection and Regulatory Compliance
4.6.2. Prevention of Cyber Attacks
4.6.3. Ransomware
4.6.4. Security Audits and Incident Management

4.7. Virtual Reality (RV) and Augmented Reality (RA) in Medicine

4.7.1. Medical Training using VR Simulators
4.7.2. AR Applications in Assisted Surgery
4.7.3. Surgical Guides
4.7.4. VR Therapy and Rehabilitation

4.8. Robotics in Medicine

4.8.1. Use of Surgical Robots in Medical Procedures
4.8.2. Automation of Tasks in Hospitals and Laboratories
4.8.3. Prosthesis
4.8.4. Robotic Assistance in Rehabilitation

4.9. Medical Images Analysis

4.9.1. Medical Image Processing and Computational Analysis
4.9.2. Computer-Aided Image Diagnosis
4.9.3. Real-Time Medical Imaging
4.9.4. 3D

4.10. Blockchain in Healthcare

4.10.1. Security and Traceability of Health Data with Blockchain
4.10.2. Exchange of Medical Information between Institutions
4.10.3. Management of Informed Consent
4.10.4. Privacy

Module 5. Market Access (1). Organization and Processes

5.1. Market Access in the Pharmaceutical Industry

5.1.1. What Do We Mean by Market Access?
5.1.2. Why is a Market Access Department Necessary?
5.1.3. Functions of the Market Access Department
5.1.4. Conclusions

5.2. Authorization and Registration of New Drugs

5.2.1. Health Authorities
5.2.2. European Medicines Agency (EMA)
5.2.3. New Drug Marketing Authorization Process: Centralized, Decentralized and Mutual Recognition Processes

5.3. Evaluation of New Drugs at National Level

5.3.1. Health Technology Assessment Agencies.
5.3.2. Relations
5.3.3. Europe
5.3.4. Therapeutic Positioning Reports (TPR)
5.3.5. Decision Makers and Influencers

5.4. Other New Drug Evaluations

5.4.1. GENESIS Group Evaluations
5.4.2. Regional Evaluations
5.4.3. Evaluations in Hospital Pharmacies: Pharmacy and Therapeutics Committees
5.4.4. Other Evaluations

5.5. From Drug Approval to Availability to the Patient

5.5.1. New Drug Pricing and Reimbursement Application Process
5.5.2. Marketing and Financing Conditions
5.5.3. Procedure for Access to Medicines at Hospital Level
5.5.4. Access Procedure for Drugs Dispensed in Street Pharmacies
5.5.5. Access to Generic and Biosimilar Drugs

5.6. Drug Financing

5.6.1. Traditional Versus New Financing Schemes
5.6.2. Innovative Agreements
5.6.3. Risk-Sharing Agreements (RSAs)
5.6.4. Types of RSA
5.6.5. Criteria for RSA Selection

5.7. Medication Purchasing Process

5.7.1. Public Contracting
5.7.2. Centralized Purchasing of Medicines and Medical Devices
5.7.3. Framework Agreements
5.7.4. Conclusions

5.8. Market Access Department (1). Professional Profiles

5.8.1. Evolution of the Market Access Professional Profile
5.8.2. Professional Profiles in Market Access
5.8.3. Market Access Manager
5.8.4. Pharmaco-economics
5.8.5. Pricing
5.8.6. Key Account Manager

5.9. Market Access Department (2). Interaction with Other Departments of the Pharmaceutical Industry

5.9.1. Marketing and Sales
5.9.2. Medical Department
5.9.3. Institutional Relations
5.9.4. Regulatory
5.9.5. Communication

Module 6. Market Access (2). Tools and Strategy

6.1. Market Access Planning for a Drug

6.1.1. Analysis of the Current Scenario: Management of the Disease, Competitors
6.1.2. Region and Account Segmentation
6.1.3. Scientific Societies
6.1.4. Patient Associations
6.1.5. Designing the Corporate Strategy
6.1.6. Strategy Implementation Chronology

6.2. Market Access Management for a Drug

6.2.1. Access Management at Regional Level
6.2.2. Access to the Hospital Drug Market. Hospital Pharmacy Management and Strategy
6.2.3. Access to the Street Pharmacy Drug Market
6.2.4. Primary Care Pharmacist Management and Strategy

6.3. Clinical Value of a Drug

6.3.1. Value Based on Clinical Development
6.3.2. Real Life Studies
6.3.3. (RWD/RWE)
6.3.4. Conclusions

6.4. Value Perceived by the Patient

6.4.1. Patient Reported Outcomes, PRO)
6.4.2. Quality of Life Related to Health (CVRS)
6.4.3. Treatment Satisfaction
6.4.4. Incorporation of Patient Preferences

6.5. Economic Analysis. Types

6.5.1. Types of Economic Analysis
6.5.2. Parameters to be Defined
6.5.3. Partial Economic Assessments
6.5.4. Costs and Burden of the Disease
6.5.5. Cost Consequence

6.6. Studies of Economic Analysis

6.6.1. Budget Impact Studies
6.6.2. Market Growth
6.6.3. Associated Risks
6.6.4. Intellectual Property

6.7. Assessments of Economic Analysis

6.7.1. Full Economic Assessments
6.7.2. Cost-Effectiveness Analysis
6.7.3. Cost-Utility Analysis
6.7.4. Cost-Benefit Analysis
6.7.5. Decision Rules

6.8. Drug Value Dossier

6.8.1. Contents of the Value Dossier
6.8.2. The Clinical Value of the Drug
6.8.3. The Economic Value of the Drug
6.8.4. Demonstrating the Value of the Drug to the Healthcare System
6.8.5. Adaptation of the Dossier to the different Autonomous Communities

6.9. Documents Required for the Price and Reimbursement Request

6.9.1. Documentation Requirements
6.9.2. Optional Documents
6.9.3. Price Documents
6.9.4. Reimbursement Documents

6.10. New Trends

6.10.1. Value-Based Purchasing
6.10.2. Multi-Criteria Analysis (MCA)
6.10.3. Innovative Public Procurement
6.10.4. Latest Trends

Module 7. Integral Coaching in Pharma Biotech

7.1. Basics of Coaching in Pharma Biotech

7.1.1. Coaching Skills and Ethics
7.1.2. The Essence of Coaching
7.1.3. Learning to Learn
7.1.4. Recommended Film: Pacific Warrior

7.2. The Coaching Process - Schools and Models

7.2.1. North American Coaching Contributions
7.2.2. Contributions of Humanistic-European Coaching
7.2.3. Ontological American Coaching Contributions
7.2.4. Conclusions

7.3.    The Coachee-Client

7.3.1. Present - Breakdown - Objectives
7.3.2. How to Know about the Situation of Each Person in a Professional Team and Therefore Be Able to Overcome Problems in Order to Achieve the Objectives
7.3.3. Know the Current Situation through the Tool "THE WHEEL OF PROFESSIONAL LIFE".
7.3.4. Conclusions

7.4. Ideal Situation

7.4.1. Where I Am Going
7.4.2. Identify Goal, Vision and Clarification of Objectives. Both as an Individual Professional and as a Team Coordinator
7.4.3. Grow Model
7.4.4. Example: Where You Want to Have Each Member of Your Team through a Mandala

7.5. The Technique Our Mind

7.5.1. Mental Models
7.5.2. Observe, Distinguish
7.5.3. Beliefs, Judgments
7.5.4. Facts and Opinions

7.6. The Technique Language

7.6.1. Basic Postulates of the Ontology of Language according to Rafael Echevarría
7.6.2. Competence of Listening, Silence and Speech.
7.6.3. Recommended Books
7.6.4. Rafael Echevarría. Ontology of Language
7.6.5. Leonardo Wolk. The Art of Blowing Embers

7.7. Techniques. Emotion

7.7.1. Management and Emotional Intelligence
7.7.2. Legitimize Emotion to Manage it from the Linguistic Dimensions
7.7.3. Emotional
7.7.4. Conclusions

7.8. Technique - Corporeality

7.8.1. Who Am I From My Body?
7.8.2. Posture and Movement
7.8.3. Trends that Support or Block Conversations with the Body
7.8.4. Conclusions

7.9. Powerful Questions. How to Use Questions to Help Each Member of your Team Find their Best Version of Themselves

7.9.1. To Determine Our Client's Profile and Design an Action Plan
7.9.2. Coaching Questions to Reconnect
7.9.3. Coaching Questions to Change Perspective
7.9.4. Coaching Questions for Awareness
7.9.5. Coaching Questions to Create Action
7.9.6. Coaching Questions for Goal Setting
7.9.7. Coaching Questions to Design an Action Plan
7.9.8. Coaching Questions for the Client to Find their Own Solutions

7.10. The Action

7.10.1.  Phases of the Action Plan
7.10.2. Accompaniment
7.10.3. Monitoring
7.10.4. Commitment
7.10.5. How to Elaborate an Action Plan with Each Delegate of Your Team

Module 8. The Medical Department

8.1. The Medical Department

8.1.1. General Structure of the Medical Department in Different Companies
8.1.2.  Purpose and Functions of the Department
8.1.3. Roles in the Medical Department
8.1.4. How they Relate to Other Departments: Marketing, Access, Sales, etc.
8.1.5. Career Opportunities for the Medical Department in the Pharmaceutical Industry

8.2. Monitoring

8.2.1. Fundamentals of Clinical Development
8.2.2. Legislation in Clinical Trials
8.2.3. Types of Clinical Trials
8.2.4. Clinical Trials Phases

8.2.4.1. Phase I Clinical Studies
8.2.4.2. Phase II Clinical Studies
8.2.4.3. Phase III Clinical Studies
8.2.4.4. Phase IV Clinical Studies

8.3. Clinical Trials Methodology

8.3.1. Clinical Trial Design
8.3.2. Stages in the Development of Clinical Trials
8.3.3. Clinical Trials Viability
8.3.4. Identification and Selection of Researcher Centers
8.3.5. Recruitment Materials and Strategies
8.3.6. Contracts with Research Centers
8.3.7. Protocol

8.4. Trial Monitoring: Monitoring and Control

8.4.1. Monitoring Visit

8.4.1.1. Pre-Study Visit
8.4.1.2. Initiation Visit
8.4.1.3. Monitoring Visit
8.4.1.4. Closing Visit

8.4.2. Remote Monitoring
8.4.3. Monitoring Visit Reports
8.4.4. Data Management Obtaining Results

8.5. Real Clinical Practice Studies. RWE

8.5.1. RWE Studies: Design, Analysis, Minimization of Bias
8.5.2. Types of RWE Study
8.5.3. Integration in the Medical Plan
8.5.4. Inquiry and Communication of Results
8.5.5. Current Challenges in the Use of Evidence and Knowledge of RWE
8.5.6. How RWE Can Support Decision Making throughout the Product Life Cycle
8.5.7. Investigator Initiated Studies/Trials and Research Collaborations

8.6. The Medical Affairs Department

8.6.1. What is the Medical Affairs Department?

8.6.1.1. Purpose and Functions of the Department
8.6.1.2. General Structure of the Department in Different Companies
8.6.1.3. Interactions Between Medical Affairs And Other Departments (Clinical Operations & Commercial Departments)
8.6.1.4. The Relationship of Medical Issues in Terms of Product Life Cycle

8.6.2. Creation of State-of-the-art Data Generation Programs
8.6.3. Medical's Co-leadership Role
8.6.4. Affairs in Cross-functional Pharmaceutical Organizations

8.7. Roles in the Medical Affairs Department

8.7.1.  Role of the Medical Advisor
8.7.2. Functions of the Medical Advisor
8.7.3. Participation tactics with HCP

8.7.3.1. Advisory Board and Promotion Programs
8.7.3.2. Scientific Publications
8.7.3.3. Planning of Scientific Congresses

8.7.4. Elaboration of a Medical Communication Plan
8.7.5. Design of Medical Product Strategy
8.7.6. Management of Medical Projects and Studies Based on Real Clinical Practice Data (RWE)

8.7.7. Role of the Medical Science Liaison

8.7.7.1. MSL Functions: Medical Communication and Interlocutors
8.7.7.2. Implementation of Medical Projects and Territorial Management
8.7.7.3. Investigator Initiated Studies/Trials and Research Collaborations
8.7.7.4. Scientific Communication and Insights Gathering

8.8. Compliance In the Medical Affairs Department

8.8.1. Concept of Compliance in the Medical Department

8.8.1.1. Promotion of Prescription Drugs
8.8.1.2. Interrelation with Health Professionals and Organizations
8.8.1.3. Interrelation with Patient Organizations

8.8.2. Definition of On Label/Off Label
8.8.3. Differences between Commercial Department and Medical Affairs
8.8.4. Code of Good Clinical Practice in Medical Promotion and Information

8.9. Medical Reports

8.9.1. Comprehensive Communication Plan
8.9.2. Media and Omnichannel Plan
8.9.3. Integration of the Communication Plan in the Medical Plan
8.9.4. Information Resources in Biomedicine

8.9.4.1. International Sources: Pubmed, Embase, WOS, etc.
8.9.4.2. Sources in Latin America: CSIC , Ibecs, LILACS, Indexes etc.
8.9.4.3. Sources for Locating Clinical Trials: WHO, ClinicalTrials, Cochrane CENTRAL, etc.
8.9.4.4. Drug Information Sources: Bot Plus Web, FDA, etc.
8.9.4.5. Other Resources: Official Bodies, Web Pages, Scientific Societies, Associations, Evaluation Agencies, etc.

8.10. Pharmacovigilance

8.10.1. Pharmacovigilance in Clinical Trials

8.10.1.1. Legal Framework and Definitions
8.10.1.2. Adverse Event Management

8.10.2. Notification of Adverse Events, Eudravigilance
8.10.3. Periodic Security Reports
8.10.4. Pharmacovigilance in Other Clinical Trials: Post-authorization Studies

Module 9. Team Leadership in Pharma

9.1. Leadership

9.1.1. Introduction to Leadership
9.1.2. Power and Influence
9.1.3. What is Leadership?
9.1.4. Conclusions

9.2. Leadership Theory

9.2.1. Leadership Process
9.2.2. Leadership Styles
9.2.3. Leadership Models
9.2.4. Evolution

9.3. Leadership Skills

9.3.1. Communication
9.3.2. Commitment
9.3.3. Motivation
9.3.4. Decision Making

9.4. Group Management

9.4.1. Organization
9.4.2. Time Management
9.4.3. Planning and Objectives
9.4.4. Equipment Assessment

9.5. Skills for Team Management

9.5.1. Goals
9.5.2. Objectives
9.5.3. Time Management
9.5.4. Problem Management

9.6. Decision Making

9.6.1. Process
9.6.2. Team Decision Making
9.6.3. Strategic Decisions
9.6.4. Ethical Decisions

9.7. Communication, Part of Success

9.7.1. External Communication
9.7.2. Internal Communication
9.7.3. Crisis Communication
9.7.4. Intercultural Communication

9.8. Negotiation and Conflict Management

9.8.1. Communication Strategies
9.8.2. Skills
9.8.3. Conflict Management
9.8.4. Team Negotiation

9.9. People Development

9.9.1. Equipment
9.9.2. Motivation
9.9.3. Visibility
9.9.4. Conclusions

9.10. Common Objective, Project Developmen

9.10.1. Common Objective, Which One is It?
9.10.2. Multidisciplinary Teams
9.10.3. Building Alliances
9.10.4. Most used Strategies

Module 10. The Business Plan in the Territory

10.1. The Business Plan

10.1.1. What is a Business Plan?
10.1.2. Purpose and Objectives of a Business Plan
10.1.3. Why is a Business Plan Important?
10.1.4. When to Make a Business Plan

10.2. Context of the Pharmaceutical Industry

10.2.1. Structural Situation of the Pharmaceutical Industry
10.2.2. Key People and Departments in the Development of an Action Plan
10.2.3. General Management

10.2.3.1. Sales Management
10.2.3.2. The Marketing Department
10.2.3.3. Medical Department
10.2.3.4. The Financial Department
10.2.3.5. The Regulatory Department

10.2.4. Current Challenges of the Pharmaceutical Industry

10.3. Stages for Defining a Business Plan

10.3.1. Defining Objectives
10.3.2. Product Description: Key Attributes
10.3.3. What Information Do I Need to Make a Plan?
10.3.4. Alignment with Strategy
10.3.5. Define Timings
10.3.6. Defining Resources
10.3.7. Establish Results

10.4. Business and Marketing Plan

10.4.1. Commercial Resources to Establish a Plan
10.4.2. Choice of the Plan according to Our Objective
10.4.3. Marketing Strategy: Alignment
10.4.4. Marketing Resources as Leverage

10.5. Customer Analysis

10.5.1. Customer Relationship Management
10.5.2. Identifying Customer Needs
10.5.3. Communication With Client
10.5.4. Conclusions

10.6. Competitive Analysis

10.6.1. Market Segmentation
10.6.2. Competitive Analysis of Your Product
10.6.3. Commercial Strategies Facing the Competition
10.6.4. Expansion Plans
10.6.5. Defense Plans

10.7. Economic Analysis of the Business Plan

10.7.1. Estimation of Costs and Objectives
10.7.2. Investment Sources and Strategies
10.7.3. Financial Risk Analysis
10.7.4. Assessment of Return of Investment

10.8. Implementation and Follow-Up of the Business Plan

10.8.1. Agenda of the Business Plan
10.8.2. Process Monitoring and Review Mechanisms According to Evolution
10.8.3. KPI: Objective Performance Indicators
10.8.4. Conclusions

10.9. Final Analysis of the Business Plan

10.9.1. Meeting Deadlines
10.9.2. Analysis of Results
10.9.3. Budget Analysis

10.10. Pharma Biotech Marketing Plan

10.10.1. Market Analysis
10.10.2. Competition
10.10.3. Target Audience
10.10.4. Brand Positioning

Module 11. Leadership, Ethics and Social Responsibility in Companies 

11.1. Globalization and Governance 

11.1.1. Governance and Corporate Governance 
11.1.2. The Fundamentals of Corporate Governance in Companies 
11.1.3. The Role of the Board of Directors in the Corporate Governance Framework 

11.2. Cross-Cultural Management 

11.2.1. Concept of Cross-Cultural Management
11.2.2. Contributions to the Knowledge of National Cultures
11.2.3. Diversity Management 

11.3. Sustainability

11.3.1. Sustainability and Sustainable Development
11.3.2. The 2030 Agenda    
11.3.3. Sustainable Companies 

11.4. Responsible Management Systems and Tools 

11.4.1. CSR: Corporate Social Responsibility
11.4.2. Essential Aspects for Implementing a Responsible Management Strategy
11.4.3. Steps for the Implementation of a Corporate Social Responsibility Management System
11.4.4. Tools and Standards of CSR 

11.5. Multinationals and Human Rights 

11.5.1. Globalization, Multinational Corporations and Human Rights 
11.5.2. Multinational Corporations and International Law
11.5.3. Legal Instruments for Multinationals in the Field of Human Rights 

11.6. Legal Environment and Corporate Governance 

11.6.1. International Rules on Importation and Exportation 
11.6.2. Intellectual and Industrial Property
11.6.3. International Labor Law 

Module 12. People and Talent Management 

12.1. Strategic People Management 

12.1.1. Strategic Human Resources Management
12.1.2. Strategic People Management 

12.2. Human Resources Management by Competencies 

12.2.1. Analysis of the Potential
12.2.2. Remuneration Policy
12.2.3. Career/Succession Planning 

12.3. Performance Evaluation and Performance Management 

12.3.1. Performance Management
12.3.2. Performance Management: Objectives and Process 

12.4. Motivation 

12.4.1. The Nature of Motivation 
12.4.2. Expectations Theory
12.4.3. Needs Theory
12.4.4. Motivation and Financial Compensation 

12.5. Developing High Performance Teams 

12.5.1. High-Performance Teams: Self-Managing Teams 
12.5.2. Methodologies for Managing High Performance Self-Managed Teams 

12.6. Change Management 

12.6.1. Change Management
12.6.2. Types of Change Management Processes
12.6.3. Stages or Phases in Change Management 

12.7. Productivity, Attraction, Retention and Activation of Talent 

12.7.1. Productivity 
12.7.2. Talent Attraction and Retention Levers 

Module 13. Economic and Financial Management 

13.1. Economic Environment

13.1.1. Macroeconomic Environment and the National Financial System 
13.1.2. Financial Institutions 
13.1.3. Financial Markets 
13.1.4. Financial Assets
13.1.5. Other Financial Sector Entities     

13.2. Executive Accounting 

13.2.1. Basic Concepts 
13.2.2. The Company's Assets  
13.2.3. The Company's Liabilities  
13.2.4. The Company's Net Worth  
13.2.5. The Income Statement  

13.3. Information Systems and Business Intelligence 

13.3.1. Fundamentals and Classification 
13.3.2. Cost Allocation Phases and Methods 
13.3.3. Choice of Cost Center and Impact 

13.4. Budget and Management Control 

13.4.1. The Budgetary Model  
13.4.2. The Capital Budget 
13.4.3. The Operating Budget  
13.4.5. The Cash Budget  
13.4.6. Budget Monitoring  

13.5. Financial Management 

13.5.1. The Company's Financial Decisions  
13.5.2. The Financial Department  
13.5.3. Cash Surpluses  
13.5.4. Risks Associated with Financial Management  
13.5.5. Risk Management of the Financial Management  

13.6. Financial Planning 

13.6.1. Definition of Financial Planning 
13.6.2. Actions to Be Taken in Financial Planning 
13.6.3. Creation and Establishment of the Business Strategy  
13.6.4. The Cash Flow Chart 
13.6.5. The Working Capital Chart 

13.7. Corporate Financial Strategy 

13.7.1. Corporate Strategy and Sources of Financing  
13.7.2. Corporate Financing Financial Products 

13.8. Strategic Financing 

13.8.1. Self-financing  
13.8.2. Increase in Shareholder's Equity 
13.8.3. Hybrid Resources 
13.8.4. Financing through Intermediaries 

13.9. Financial Analysis and Planning     

13.9.1. Analysis of the Balance Shee
13.9.2. Analysis of the Income Statement 
13.9.3. Profitability Analysis 

13.10.  Analyzing and Solving Cases/Problems 

13.10.1. Financial Information on Industria de Diseño y Textil, S.A. (INDITEX) 

Module 14. Commercial Management and Strategic Marketing 

14.1. Commercial Management 

14.1.1. Conceptual Framework of Commercial Management 
14.1.2. Commercial Strategy and Planning 
14.1.3. The Role of Sales Managers 

14.2. Marketing  

14.2.1. The Concept of Marketing 
14.2.2. The Basic Elements of Marketing 
14.2.3. Marketing Activities in Companies 

14.3. Strategic Marketing Management 

14.3.1. The Concept of Strategic Marketing 
14.3.2. Concept of Strategic Marketing Planning 
14.3.3. Stages in the Process of Strategic Marketing Planning 

14.4. Digital Marketing and e-Commerce 

14.4.1. Objectives of Digital Marketing and e-Commerce 
14.4.2. Digital Marketing and the Media It Uses  
14.4.3. E-Commerce. General Context  
14.4.4. Categories of e-Commerce  
14.4.5. Advantages and Disadvantages of e-Commerce Compared to Traditional Commerce 

14.5. Digital Marketing to Reinforce a Brand 

14.5.1. Online Strategies to Improve Brand Reputation 
14.5.2. Branded Content and Storytelling     

14.6. Digital Marketing to Attract and Retain Customers  

14.6.1. Loyalty and Engagement Strategies Using the Internet 
14.6.2. Visitor Relationship Management 
14.6.3. Hypersegmentation 

14.7. Digital Campaign Management 

14.7.1. What Is a Digital Advertising Campaign?     
14.7.2. Steps to Launch an Online Marketing Campaign 
14.7.3. Mistakes in Digital Advertising Campaigns     

14.8. Sales Strategy  

14.8.1. Sales Strategy 
14.8.2. Sales Methods 

14.9. Corporate Communication  

14.9.1 Concept
14.9.2. The Importance of Communication in the Organization 
14.9.3. Type of Communication in the Organization 
14.9.4. Functions of Communication in the Organization 
14.9.5. Elements of Communication 
14.9.6. Problems of Communication 
14.9.7. Communication Scenarios 

14.10. Digital Communication and Reputation 

14.10.1. Online Reputation  
14.10.2. How to Measure Digital Reputation?  
14.10.3. Online Reputation Tools  
14.10.4. Online Reputation Report  
14.10.5. Online Branding 

Module 15. Executive Management 

15.1. General Management  

15.1.1. The Concept of General Management  
15.1.2. The Role of the CEO 
15.1.3. The CEO and their Responsibilities 
15.1.4. Transforming the Work of Management

 15.2.  Manager Functions: Organizational Culture and Approaches 

15.2.1. Manager Functions: Organizational Culture and Approaches 

15.3. Operations Management  

15.3.1. The Importance of Management     
15.3.2. Value Chain     
15.3.3. Quality Management

15.4. Public Speaking and Spokesperson Education 

15.4.1. Interpersonal Communication 
15.4.2. Communication Skills and Influence 
15.4.3. Communication Barriers 

15.5. Personal and Organizational Communication Tools     

15.5.1. Interpersonal Communication
15.5.2. Interpersonal Communication Tools 
15.5.3. Communication in the Organization 
15.5.4. Tools in the Organization 

15.6. Communication in Crisis Situations 

15.6.1. Crisis 
15.6.2. Phases of the Crisis 
15.6.3. Messages: Contents and Moments 

15.7. Preparation of a Crisis Plan 

15.7.1. Analysis of Possible Problems 
15.7.2. Planning 
15.7.3. Adequacy of Personnel 

15.8. Personal Branding 

15.8.1. Strategies for Personal Brand Development 
15.8.2. Personal Branding Laws 
15.8.3. Tools for Creating Personal Brands

Take this Master's Degree and obtain the most updated knowledge in strategic management in a constantly growing industry such as pharmaceuticals"